Analyst firms · Rosenblatt · SPOT

Rosenblatt SPOT price target and rating history

Spotify Technology S.A. (SPOT) · Consumer Discretionary

Rosenblatt rates Spotify Technology S.A. (SPOT) Buy with a $500 price target, as of its latest action on Apr 29, 2026. It has published 5 rating actions on SPOT since February 2022, including 2 upgrades and 1 downgrade. Across 10 firms with a SPOT price target in the last 12 months, the median target is $563. Rosenblatt's $500 is 11% below that.

Current rating
Buy
Price target
$500
Median target, all firms
$563
Actions on SPOT
5

Rosenblatt price target on SPOT

$500$325$1502023202420252026
Rosenblatt price target on SPOT, each point a stated target, February 2022 to April 2026.

Every Rosenblatt rating on SPOT

How other firms rate SPOT

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Piper SandlerNeutral$540Oct 8, 2026
RosenblattBuy$500Apr 29, 2026
Pivotal Research GroupHold$400Apr 29, 2026
Morgan StanleyOverweight$630Apr 13, 2026
DaiwaOutperform$535Mar 26, 2026
Arete ResearchBuy$586Feb 26, 2026
CitigroupBuy$650Jan 30, 2026
MoffettNathansonNeutral$487Jan 27, 2026
Goldman SachsBuy$700Jan 23, 2026
Citizens JMPMkt Outperform$800Dec 17, 2025
Erste GroupHoldDec 5, 2025

Questions about Rosenblatt and SPOT

What is Rosenblatt's price target for SPOT?
Rosenblatt's latest stated price target for Spotify Technology S.A. (SPOT) is $500, from its action on Apr 29, 2026.
What is Rosenblatt's rating on SPOT?
Rosenblatt rates SPOT Buy, a bullish rating, as of Apr 29, 2026.
When did Rosenblatt last change its view on SPOT?
On Apr 29, 2026, Rosenblatt upgrades to Buy from Neutral, price target $500.
How does Rosenblatt's SPOT target compare with other analysts?
Across 10 firms with a SPOT price target in the last 12 months, the median target is $563. Rosenblatt's $500 is 11% below that.

More SPOT rating histories

All Rosenblatt ratingsSPOT news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.